Sort by
Items per page

Send to

Choose Destination

Best matches for irritable bowel Lactobacillus:

Search results

Items: 1 to 20 of 236


Probiotics in Disease Prevention and Treatment.

Liu Y, Tran DQ, Rhoads JM.

J Clin Pharmacol. 2018 Oct;58 Suppl 10:S164-S179. doi: 10.1002/jcph.1121.


Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling.

Scriven M, Dinan TG, Cryan JF, Wall M.

Diseases. 2018 Sep 6;6(3). pii: E78. doi: 10.3390/diseases6030078. Review.


Mind the gut: probiotics in paediatric neurogastroenterology.

Salvatore S, Pensabene L, Borrelli O, Saps M, Thapar N, Concolino D, Staiano A, Vandenplas Y.

Benef Microbes. 2018 Sep 10:1-16. doi: 10.3920/BM2018.0013. [Epub ahead of print]


The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.

Hod K, Dekel R, Aviv Cohen N, Sperber A, Ron Y, Boaz M, Berliner S, Maharshak N.

Neurogastroenterol Motil. 2018 Aug 23:e13456. doi: 10.1111/nmo.13456. [Epub ahead of print]


Therapeutic effects of kefir grain Lactobacillus-derived extracellular vesicles in mice with 2,4,6-trinitrobenzene sulfonic acid-induced inflammatory bowel disease.

Seo MK, Park EJ, Ko SY, Choi EW, Kim S.

J Dairy Sci. 2018 Oct;101(10):8662-8671. doi: 10.3168/jds.2018-15014. Epub 2018 Aug 9.


Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids.

Han X, Lee A, Huang S, Gao J, Spence JR, Owyang C.

Gut Microbes. 2018 Jul 24:1-18. doi: 10.1080/19490976.2018.1479625. [Epub ahead of print]


Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome.

Su T, Liu R, Lee A, Long Y, Du L, Lai S, Chen X, Wang L, Si J, Owyang C, Chen S.

Gastroenterol Res Pract. 2018 Jun 5;2018:6961783. doi: 10.1155/2018/6961783. eCollection 2018.


Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.

Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S.

Benef Microbes. 2018 Sep 18;9(5):697-706. doi: 10.3920/BM2017.0105. Epub 2018 Jun 11.


Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial.

Cremon C, Guglielmetti S, Gargari G, Taverniti V, Castellazzi AM, Valsecchi C, Tagliacarne C, Fiore W, Bellini M, Bertani L, Gambaccini D, Cicala M, Germanà B, Vecchi M, Pagano I, Barbaro MR, Bellacosa L, Stanghellini V, Barbara G.

United European Gastroenterol J. 2018 May;6(4):604-613. doi: 10.1177/2050640617736478. Epub 2017 Oct 8.


Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.

Yoon JY, Cha JM, Oh JK, Tan PL, Kim SH, Kwak MS, Jeon JW, Shin HP.

Dig Dis Sci. 2018 Jun 7. doi: 10.1007/s10620-018-5139-8. [Epub ahead of print]


Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.

Wegh CAM, Benninga MA, Tabbers MM.

J Clin Gastroenterol. 2018 May 18. doi: 10.1097/MCG.0000000000001054. [Epub ahead of print]


A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome.

Shin SP, Choi YM, Kim WH, Hong SP, Park JM, Kim J, Kwon O, Lee EH, Hahm KB.

J Clin Biochem Nutr. 2018 Mar;62(2):179-186. doi: 10.3164/jcbn.17-73. Epub 2018 Jan 11.


Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.

Leventogiannis K, Gkolfakis P, Spithakis G, Tsatali A, Pistiki A, Sioulas A, Giamarellos-Bourboulis EJ, Triantafyllou K.

Probiotics Antimicrob Proteins. 2018 Mar 5. doi: 10.1007/s12602-018-9401-3. [Epub ahead of print] Erratum in: Probiotics Antimicrob Proteins. 2018 Mar 28;:.


Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells.

Cao YN, Feng LJ, Wang BM, Jiang K, Li S, Xu X, Wang WQ, Zhao JW, Wang YM.

Saudi J Gastroenterol. 2018 Jan-Feb;24(1):59-66. doi: 10.4103/sjg.SJG_333_17.


Consumption of a Low Fermentable Oligo-, Di-, Mono-saccharides, and Polyols Diet and Irritable Bowel Syndrome: A Systematic Review.

Pourmand H, Esmaillzadeh A.

Int J Prev Med. 2017 Dec 13;8:104. doi: 10.4103/ijpvm.IJPVM_175_17. eCollection 2017. Review.


Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome.

Cao YN, Feng LJ, Liu YY, Jiang K, Zhang MJ, Gu YX, Wang BM, Gao J, Wang ZL, Wang YM.

World J Gastroenterol. 2018 Jan 21;24(3):338-350. doi: 10.3748/wjg.v24.i3.338.


Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation.

Ait-Belgnaoui A, Payard I, Rolland C, Harkat C, Braniste V, Théodorou V, Tompkins TA.

J Neurogastroenterol Motil. 2018 Jan 30;24(1):138-146. doi: 10.5056/jnm16167.


Wuji Wan Formula Ameliorates Diarrhea and Disordered Colonic Motility in Post-inflammation Irritable Bowel Syndrome Rats by Modulating the Gut Microbiota.

Chen Y, Xiao S, Gong Z, Zhu X, Yang Q, Li Y, Gao S, Dong Y, Shi Z, Wang Y, Weng X, Li Q, Cai W, Qiang W.

Front Microbiol. 2017 Nov 23;8:2307. doi: 10.3389/fmicb.2017.02307. eCollection 2017.


Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.

Zhong W, Lu X, Shi H, Zhao G, Song Y, Wang Y, Zhang J, Jin Y, Wang S.

J Clin Gastroenterol. 2017 Nov 28. doi: 10.1097/MCG.0000000000000961. [Epub ahead of print]


Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.

Sadrin S, Sennoune SR, Gout B, Marque S, Moreau J, Grillasca J, Pons O, Maixent JM.

Cell Mol Biol (Noisy-le-grand). 2017 Sep 30;63(9):122-131. doi: 10.14715/cmb/2017.63.9.21.


Supplemental Content

Loading ...
Support Center